Mednax Inc (MD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mednax Inc (MD) has a cash flow conversion efficiency ratio of -0.147x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-129.50 Million) by net assets ($878.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MD equity to assets ratio to measure how much of total assets are equity-financed.
Mednax Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Mednax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Mednax Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Mednax Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mednax Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hong Ri Da Technology Co. Ltd. A
SHE:301285
|
N/A |
|
Lianhe Chemical Technology Co Ltd
SHE:002250
|
0.079x |
|
Xuzhou Handler Special Vehicle Co Ltd
SHE:300201
|
0.029x |
|
Suzhou Secote Precision Electronic Co Ltd Class A
SHG:603283
|
0.039x |
|
Getty Realty Corporation
NYSE:GTY
|
0.030x |
|
Choice International Limited
NSE:CHOICEIN
|
-0.037x |
|
Domain Holdings Australia Ltd
AU:DHG
|
0.049x |
|
Netstreit Corp
NYSE:NTST
|
0.017x |
Annual Cash Flow Conversion Efficiency for Mednax Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Mednax Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see Mednax Inc (MD) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $865.85 Million | $271.09 Million | 0.313x | +15.94% |
| 2024-12-31 | $764.94 Million | $206.57 Million | 0.270x | +66.97% |
| 2023-12-31 | $849.06 Million | $137.32 Million | 0.162x | -13.62% |
| 2022-12-31 | $891.63 Million | $166.94 Million | 0.187x | +118.78% |
| 2021-12-31 | $896.69 Million | $76.74 Million | 0.086x | -68.73% |
| 2020-12-31 | $747.72 Million | $204.62 Million | 0.274x | +18.34% |
| 2019-12-31 | $1.50 Billion | $346.64 Million | 0.231x | +146.29% |
| 2018-12-31 | $3.09 Billion | $289.93 Million | 0.094x | -43.70% |
| 2017-12-31 | $3.07 Billion | $511.38 Million | 0.167x | +3.75% |
| 2016-12-31 | $2.76 Billion | $443.78 Million | 0.161x | +6.28% |
| 2015-12-31 | $2.44 Billion | $368.70 Million | 0.151x | -18.93% |
| 2014-12-31 | $2.27 Billion | $422.64 Million | 0.187x | +7.82% |
| 2013-12-31 | $2.34 Billion | $405.40 Million | 0.173x | +8.13% |
| 2012-12-31 | $2.04 Billion | $325.69 Million | 0.160x | +2.20% |
| 2011-12-31 | $1.73 Billion | $271.02 Million | 0.157x | -5.79% |
| 2010-12-31 | $1.45 Billion | $240.56 Million | 0.166x | -18.06% |
| 2009-12-31 | $1.19 Billion | $241.37 Million | 0.203x | +7.91% |
| 2008-12-31 | $965.14 Million | $181.39 Million | 0.188x | -4.39% |
| 2007-12-31 | $959.05 Million | $188.52 Million | 0.197x | -3.99% |
| 2006-12-31 | $865.80 Million | $177.27 Million | 0.205x | -12.79% |
| 2005-12-31 | $691.79 Million | $162.42 Million | 0.235x | +8.33% |
| 2004-12-31 | $571.03 Million | $123.75 Million | 0.217x | +5.09% |
| 2003-12-31 | $572.38 Million | $118.03 Million | 0.206x | +15.50% |
| 2002-12-31 | $548.00 Million | $97.84 Million | 0.179x | -5.36% |
| 2001-12-31 | $478.85 Million | $90.34 Million | 0.189x | +26.24% |
| 2000-12-31 | $241.90 Million | $36.15 Million | 0.149x | +42.53% |
| 1999-12-31 | $228.90 Million | $24.00 Million | 0.105x | -35.66% |
| 1998-12-31 | $207.40 Million | $33.80 Million | 0.163x | -8.01% |
| 1997-12-31 | $163.70 Million | $29.00 Million | 0.177x | +63.15% |
| 1996-12-31 | $136.30 Million | $14.80 Million | 0.109x | +15.58% |
| 1995-12-31 | $62.80 Million | $5.90 Million | 0.094x | -71.99% |
| 1994-12-31 | $16.10 Million | $5.40 Million | 0.335x | -- |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more